The research was performed to explore the diagnosis value of dynamic serum calprotectin (SC) expression for sepsis in postoperative intensive care unit patients. One hundred sixty-three patients who met the inclusion criteria served as the study group. All cases in the study group were further divided into the sepsis subgroup (51 cases) and the nonsepsis subgroup (112 cases). Fifty healthy volunteers served as the control group. The levels of SC and other laboratory indexes including complete blood counts, leukocytes, the immature-to-total-neutrophil ratio, procalcitonin (PCT), C-reactive protein, and blood lactate were detected, cytokines [interleukin (IL)-2, IL-6, and interferon-γ] released by neutrophils were also determined. The Acute Physiology and Chronic Health Evaluation II (APACHE II) score and the Sequential Organ Failure Assessment score were calculated. The factors related to prognosis were analyzed with multivariate logistic regression analysis. The diagnostic accuracies of ΔSC [the differences of SC levels between postoperative day (POD) 1 and POD 2, 3, 5, 7] and ΔPCT (the differences of PCT levels between POD 1 and POD 2, 3, 5, 7) on sepsis were compared with other markers for sepsis. The levels of SC and cytokines were markedly increased on POD 1, 2, 3, 5, and 7 in the study group compared with the control group (P < 0.05 or P < 0.01). The same results were found in the sepsis subgroup compared with the nonsepsis subgroup (P < 0.05 or P < 0.01). Significant positive correlations between SC and cytokines were confirmed in patients of the study group (P < 0.05 or P < 0.01). APACHE II scores and the levels of SC and PCT on POD 1 were the variables significantly associated with sepsis. The diagnostic accuracies of ΔSC1–3 (sensitivity 87%, specificity 89%) and ΔPCT1–3 (sensitivity 89%, specificity 90%) for sepsis were greater than other ΔSCs and ΔPCTs. It appears that the dynamic changes in SC are of the predictive values for septic patients after major surgeries.
Get full access to this article
View all access options for this article.
References
1.
AbildtrupM, KingsleyGH, ScottDL. 2015. Calprotectin as a biomarker for rheumatoid arthritis: a systematic review. J Rheumatol, 42(5):760–770.
2.
AlibrahimB, AljasserM, SalhB. 2015. Fecal calprotectin use in inflammatory bowel disease and beyond: a mini-review. Can J Gastroenterol Hepatol, 29(3):157–163.
3.
AlkhamisT, IvićD, WagnerJ, IvićJ, DobroševićB, TurinaI, KralikK, BarbićJ. 2014. Postoperative immunosuppression markers and the occurrence of sepsis in patients with benign and malignant disease. Wien Klin Wochenschr, 126(23–24):774–784.
4.
AltrichterJ, SauerM, KaftanK, BirkenT, GlogerD, GlogerM, HenschelJ, HicksteinH, KlarE, KoballS, PertschyA, Nöldge-SchomburgG, VagtsDA, MitznerSR. 2011. Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study. Crit Care, 15(2):R82.
5.
CaraceniP, DomenicaliM, TovoliA, NapoliL, RicciCS, TufoniM, BernardiM. 2013. Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med, 24(8):721–728.
6.
DellingerRP. 2015. The surviving sepsis campaign: where have we been and where are we going?. Cleve Clin J Med, 82(4):237–244.
7.
FerreiraFL, BotaDP, BrossA, MélotC, VincentJL. 2001. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA, 286(14):1754–1758.
8.
HegazyMA, OmarAS, SamirN, MoharramA, WeberS, RadwanWA. 2014. Amalgamation of procalcitonin, C-reactive protein, and sequential organ failure scoring system in predicting sepsis survival. Anesth Essays Res, 8(3):296–301.
9.
HendersonP, AndersonNH, WilsonDC. 2014. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol, 109(5):637–645.
10.
HouwinkAP, RijkenbergS, BosmanRJ, van der VoortPH. 2016. The association between lactate, mean arterial pressure, central venous oxygen saturation and peripheral temperature and mortality in severe sepsis: a retrospective cohort analysis. Crit Care, 20(1):56.
11.
HuangLF, YaoYM, DongN, YuY, HeLX, ShengZY. 2010. Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study. Crit Care, 14(1):R3.
12.
HuangLF, YaoYM, DongN, YuY, HeLX, ShengZY. 2011a. Association of high mobility group box-1 protein levels with sepsis and outcome of severely burned patients. Cytokine, 53(1):29–34.
13.
HuangLF, YaoYM, LiJF, DongN, LiuC, YuY, HeLX, ShengZY. 2011b. Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients. PLoS One, 6(11):e25748.
14.
HuangLF, YaoYM, ShengZY. 2012. Novel insights for high mobility group box 1 protein-mediated cellular immune response in sepsis: a systemic review. World J Emerg Med, 3(3):165–171.
15.
KopteridesP, TsangarisI. 2012. Procalcitonin and sepsis: recent data on diagnostic utility prognostic potential and therapeutic implications in critically ill patients. Minerva Anestesiol, 78(7):823–835.
16.
KristensenV, LauritzenT, Jelsness-JØrgensenLP, MoumB. 2015. Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods. Scand J Clin Lab Invest, 9:1–7.
17.
KruzliakP, NovákJ, NovákM, FodorGJ. 2014. Role of calprotectin in cardiometabolic diseases. Cytokine Growth Factor Rev, 25(1):67–75.
18.
LeeH, LimCW, HongHP, JuJW, JeonYT, HwangJW, ParkHP. 2015. Efficacy of the APACHE II score at ICU discharge in predicting post-ICU mortality and ICU readmission in critically ill surgical patients. Anaesth Intensive Care, 43(2):175–186.
19.
LevyMM. 2014. Early goal-directed therapy: what do we do now?. Crit Care, 18(6):705.
Martin-LoechesI, LevyMM, ArtigasA. 2015. Management of severe sepsis: advances, challenges, and current status. Drug Des Dev Ther, 9:2079–2088.
22.
McEvoyC, KollefMH. 2013. Determinants of hospital mortality among patients with sepsis or septic shock receiving appropriate antibiotic treatment. Curr Infect Dis Rep, 15(5):400–406.
23.
MickiewiczB, TamP, JenneCN, LegerC, WongJ, WinstonBW, DoigC, KubesP, VogelHJ, Alberta Sepsis Network. 2015. Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit. Crit Care, 19(1):11.
24.
PepperRJ, WangHH, RajakarunaGK, PapakrivopoulouE, VoglT, PuseyCD, CookHT, SalamaAD. 2015. S100A8/A9 (calprotectin) is critical for development of glomerulonephritis and promotes inflammatory leukocyte-renal cell interactions. Am J Pathol, 185(5):1264–1274.
25.
PermanSM, GoyalM, GaieskiDF. 2012. Initial emergency department diagnosis and management of adult patients with severe sepsis and septic shock. Scand J Trauma Resusc Emerg Med, 20:41.
26.
PetersenB, WolfM, AustermannJ, van LentP, FoellD, AhlmannM, KupasV, LoserK, SorgC, RothJ, VoglT. 2013. The alarmin Mrp8/14 as regulator of the adaptive immune response during allergic contact dermatitis. EMBO J, 32(1):100–111.
27.
RajR, SkrifvarsM, BendelS, SelanderT, KivisaariR, SiironenJ, ReinikainenM. 2014. Predicting six-month mortality of patients with traumatic brain injury: usefulness of common intensive care severity scores. Crit Care, 18(2):R60.
28.
ReidPA, McAllisterDA, BoydAC, InnesJA, PorteousD, GreeningAP, GrayRD. 2015. Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis. Am J Respir Crit Care Med, 191(2):233–236.
29.
ReikerasO, BorgenP, ReselandJE, LyngstadaasSP. 2014. Changes in serum cytokines in response to musculoskeletal surgical trauma. BMC Res Notes, 7:128.
30.
SantonocitoC, De LoeckerI, DonadelloK, MoussaMD, MarkowiczS, GulloA, VincentJL. 2014. C-reactive protein kinetics after major surgery. Anesth Analg, 119(3):624–629.
31.
ScaioliE, CardamoneC, ScagliariniM, ZagariRM, BazzoliF, BelluzziA. 2015. Can fecal calprotectin better stratify Crohn's disease activity index?. Ann Gastroenterol, 28(2):247–252.
32.
StubljarD, SkvarcM. 2015. Effective strategies for diagnosis of systemic inflammatory response syndrome (SIRS) due to bacterial infection in surgical patients. Infect Disord Drug Targets, 15(1):53–56.
33.
SuL, HanB, LiuC, LiangL, JiangZ, DengJ, YanP, JiaY, FengD, XieL. 2012. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis, 12:157.
34.
TerrinG, PassarielloA, MangusoF, SalviaG, RapacciuoloL, MessinaF, RaimondiF, CananiRB. 2011. Serum calprotectin: an antimicrobial peptide as a new marker for the diagnosis of sepsis in very low birth weight newborns. Clin Dev Immunol, 2011:291085.
35.
WilhelmJ, HettwerS, HammerD, SchürmannM, ChristophA, AmouryM, KlössT, FinkeR, EbeltH, WerdanK. 2012. Outcome prediction using clinical scores and biomarkers in patients with presumed severe infection in the emergency department. Med Klin Intensivmed Notfmed, 107(7):558–563.
36.
WlodzimirowK, Abu-HannaA. 2013. The utility of the SOFA score for predicting mortality in critically ill cirrhotic patients receiving liver transplantation. Crit Care, 17(2):426.
37.
YeH, HeF, FeiX, LouY, WangS, YangR, HuY, ChenX. 2014. High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period. J Cardiovasc Pharmacol Ther, 19(3):290–295.
38.
ZhengY, HouJ, PengL, ZhangX, JiaL, WangX, WeiS, MengH. 2014. The pro-apoptotic and pro-inflammatory effects of calprotectin on human periodontal ligament cells. PLoS One, 9(10):e110421.
